Women’s Health & Gynaecology
-
No increased risk of menstrual changes after COVID-19 vaccine
There is no evidence of increased risk of menstrual changes after having the COVID-19 vaccine, according to a new Swedish study published today. Read more
-
NHS backs olaparib for breast and prostate cancer
A decision today to allow olaparib for NHS patients with both early-stage breast cancer and prostate cancer has been hailed a “life-changing” decision by leading specialists. Read more
-
Infertility care shows inequality around the world
Infertility care is hugely variable around the world with inadequate care in many countries, according to a new World Health Organization backed report. Read more
-
Immunotherapy available for advanced cervical cancer
Patients with advanced cervical cancer are to get a new immunotherapy treatment in England, it was announced today. Read more
-
Pandemic safe sexual activity had lasting impact
The reduction in “risky” sexual activity during the early stages of the COVID-19 pandemic continued for a year after Britain’s first lockdown, according to a major new study published today. Read more
-
Delayed embryo development linked to miscarriage
Pregnancies that end in miscarriage have embryos that take longer to develop in the womb than those that result in live births, Dutch researchers report today. Read more
-
Hormonal contraceptive-cancer link investigated
A new study has provided an updated estimate of the cancer risks linked to hormonal contraception. Read more
-
Road crashes increase pregnant women’s risk of birth complications
Pregnant women involved in road traffic collisions have an increased risk of serious birth complications, even if they suffer only minor injuries, researchers report today. Read more
-
Boost for Mediterranean diet in women’s heart risk analysis
Sticking to the Mediterranean diet may cut the risk of cardiovascular disease and death for women, according to a major new analysis published today. Read more
-
Outcome inequality in leg artery disease
Common treatments for peripheral artery disease may be prescribed less often and be less effective in women than in men, researchers say today. Read more